|Articles|July 1, 2019
- Pharmaceutical Executive-07-01-2019
- Volume 39
- Issue 7
Pharmaceutical Executive, July 2019 Issue (PDF)
Click the title above to open the Pharmaceutical Executive July 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Creating an ‘Unbossed’ Environment in the Workplaceabout 7 years ago
Proposed Rebates Rule Raises Tough Questionsabout 7 years ago
Drug Formulary Decisions: Fixing a Broken Systemabout 7 years ago
The Feasibility of Patient Insights Before Launchabout 7 years ago
Compliance Disruptorsabout 7 years ago
Asia’s Complex Compliance Landscapeabout 7 years ago
European Pricing Talks: A lot of Smoke—or is it Fire?about 7 years ago
FDA Maps Pathway to More Accessible Biosimilarsabout 7 years ago
Top Trends, Takeaways from DIAabout 7 years ago
Pharma & Biotech: Financial Pulse-Check, OutlookAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Lipfendra to reduce LDL-C in Adults with Hypercholesterolemia
2
Jasper Therapeutics to Acquire Kira Pharmaceuticals in $132 Million Merger Agreement
3
Pharmaceutical Executive Daily: FDA Approves Lipfendra
4
From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection
5